Overall, the larger part of subjects with elevated HS-cTnT values (>99th URL, i.e., >14 ng/L) died for cardiovascular diseases (20.6%, composed of 7.4% for AMI, 3.2% for stroke and 10.0% for other cardiovascular conditions), followed by cancer (14.0%), respiratory diseases (4.6%), whilst as many as 60.9% died for other causes which were not specifically described in the published report. Here, TNNT2 is linked to respiratory system disorder.